The Comparative Safety and Effectiveness of Sitagliptin in Patients with Type 2 Diabetes and Heart Failure

被引：0
|
作者：
Weir, Daniala L. [1 ]
McAlister, Finlay A. [1 ]
Senthilselvan, Sentil [1 ]
Dyck, Jason R. [1 ]
Sandhu-Minhas, Jasjeet K. [2 ]
Eurich, Dean T. [1 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
[2] Univ Alberta, Alliance Canadian Hlth Outcomes Res Diabet, Edmonton, AB, Canada
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
272
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [1] Comparative Safety and Effectiveness of Sitagliptin in Patients With Type 2 Diabetes and Heart Failure
    Weir, Daniala L.
    Senthilselvan, A.
    Dyck, Jason R.
    Sandhu-Minhas, Jasjeet K.
    Mcalister, Finlay A.
    Eurich, Dean T.
    DIABETES, 2013, 62 : A372 - A372
  • [2] Sitagliptin and heart failure hospitalization in patients with type 2 diabetes
    Tseng, Chin-Hsiao
    ONCOTARGET, 2016, 7 (38) : 62687 - 62696
  • [3] Efficacy and Safety of Sitagliptin Therapy Compared with Pioglitazone in Heart Failure Patients with Type 2 Diabetes
    Naka, Toshio
    Akagami, Takafumi
    Doi, Takashi
    Masuyama, Tohru
    Ohyanagi, Mitsumasa
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S188 - S188
  • [4] Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study
    Eurich, D. T.
    Simpson, S.
    Senthilselvan, A.
    Asche, C. V.
    Sandhu-Minhas, J. K.
    McAlister, F. A.
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [5] THE EFFECT OF SITAGLIPTIN THERAPY COMPARED WITH PIOGLITAZONE IN HEART FAILURE PATIENTS WITH TYPE 2 DIABETES
    Naka, T.
    Arii, T.
    Takahashi, K.
    Masutani, M.
    Masuyama, T.
    Ohyanagi, M.
    CARDIOLOGY, 2013, 125 : 75 - 75
  • [6] Sitagliptin and Risk of Heart Failure in Patients With Type 2 Diabetes A Meta-Analysis
    Krittanawong, Chayakrit
    Kitai, Takeshi
    Aydar, Mehmet
    Sun, Tao
    JACC-HEART FAILURE, 2016, 4 (11) : 910 - 910
  • [7] Sitagliptin, diabetes mellitus, and heart failure: an in-depth review of sitagliptin therapy and heart failure in patients with diabetes mellitus
    Mohammadjavad Sotoudeheian
    Seyed-Mohamad-Sadegh Mirahmadi
    Pedram Salehi Darjani
    Mohammad Moradi
    Mohammad Pirhayati
    Mohammad Sedigh Dakkali
    Mehdi Taghizadeh
    Reza Azarbad
    Hamidreza Pazoki Toroudi
    Diabetology International, 2025, 16 (2) : 237 - 256
  • [8] Effectiveness and Safety of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, compared with Sitagliptin in Patients with Type 2 Diabetes
    Brix, Johanna
    Gross, Jorge
    Yee, Mao Fu J.
    Kawaguchi, M.
    Canovatchel, W.
    Meininger, Gary
    Schernthaner, Guntram
    WIENER KLINISCHE WOCHENSCHRIFT, 2012, 124 : 20 - 20
  • [9] Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus
    Tago, Motoko
    Oyama, Jun-ichi
    Sakamoto, Yoshiko
    Shiraki, Aya
    Uchida, Fumi
    Chihara, Atsuko
    Ikeda, Hideo
    Kuroki, Shigetaka
    Gondo, Shigeki
    Iwamoto, Taketo
    Uchida, Yasufumi
    Node, Koichi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (04) : 631 - 639
  • [10] Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes
    Nonaka, Kenji
    Kakikawa, Taro
    Sato, Asako
    Okuyama, Kotoba
    Fujimoto, Go
    Kato, Naoki
    Suzuki, Hideyo
    Hirayama, Yukio
    Ahmed, Tuli
    Davies, Michael J.
    Stein, Peter P.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (02) : 291 - 298
12345